CVKD Earnings Date: Nov 9, 2026 (Estimated) — Cadrenal Therapeutics, Inc. Common Stock
NASDAQ
Updated
When is CVKD's next earnings date?
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 9:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.91.
How did CVKD do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Cadrenal Therapeutics, Inc. Common Stock posted EPS of -$1.14 versus the -$1.42 estimate, a beat of 15.2%. Revenue was $0. The stock's 1-day post-earnings move was +0.5%.
How much does CVKD stock move after earnings?
CVKD beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.6% (up or down) in the day after earnings.
About Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -1.42 | -1.14 | -15.15% | $0 | ✅ Beat | +0.54% | -14.52% | -43.01% |
| 2026-05-07 | Q1 2026 | -1.56 | -1.04 | +33.33% | $0 | ✅ Beat | -2.43% | -13.94% | -28.04% |
| 2026-03-31 | Q4 2025 | -1.19 | -1.41 | -18.49% | $0 | ❌ Miss | +20.47% | +1.65% | +31.53% |
| 2025-11-10 | Q3 2025 | -1.72 | -1.31 | +23.84% | $0 | ✅ Beat | -3.17% | -4.41% | -17.91% |
| 2025-08-11 | Q2 2025 | -1.71 | -1.87 | -9.36% | $0 | ❌ Miss | -1.88% | +13.72% | +17.40% |
| 2025-03-13 | Q4 2024 | -1.87 | -2.80 | -49.73% | $0 | ❌ Miss | +9.40% | +11.75% | -14.04% |
| 2024-11-07 | Q3 2024 | -1.93 | -2.18 | -12.95% | $0 | ❌ Miss | +2.39% | +4.09% | -21.12% |
| 2024-08-07 | Q2 2024 | -1.20 | -2.25 | -87.50% | $0 | ❌ Miss | +4.69% | +25.44% | +26.17% |
Showing last 8 quarters.